| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 21 May 2025 | 13 May 2025 |
| Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2025 inter alia to consider and approve 1. To consider approve & take on record the Audited Standalone and Consolidated Financial Results of the Company along with the Auditors Report for the Quarter and Year ended 31st March 2025; 2. To consider any other business with the permission of a Chairman of the Meeting. Outcome of the Meeting of Board of Directors held on Wednesday, May 21, 2025. (As Per BSE Announcement Dated on :21.05.2025) | ||
| Board Meeting | 24 Mar 2025 | 19 Mar 2025 |
| Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/03/2025 inter alia to consider and approve 1. To Review the performance of Non-Independent Directors & the Board as a whole; 2. To Review the performance of the Chairperson of the company taking into account the views of Executive Directors and Non-Executive Directors; 3. To assess the quality quantity and timeliness of flow of information between the management of the listed entity and the board of directors that is necessary for the board of directors to effectively and reasonably perform their duties. 4. Any other business with the permission of chair. Outcome of the Separate Meeting of Independent Directors of the Company Held on Monday, March 24, 2025. (As Per Bse Announcement Dated on 24.03.2025) | ||
| Board Meeting | 10 Feb 2025 | 3 Feb 2025 |
| Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 inter alia to consider and approve 1. To consider and approve Unaudited Standalone and Consolidated Financial Results of the Company along with the Limited Review Report for the quarter and nine months ended 31st December 2024; 2. To consider any other business with the permission of a Chairman. Outcome of the Meeting of Board of Directors held on Monday, February 10, 2025. (As Per BSE Announcement dated on 10.02.2025) | ||
| Board Meeting | 12 Nov 2024 | 5 Nov 2024 |
| Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve 1. To consider and approve Un-audited Standalone and Consolidated Financial Results of the Company along with the Limited Review Report for the quarter and half year ended September 30 2024; 2. To consider any other business with the permission of a Chairman. Outcome of the Meeting of Board of Directors held on Tuesday, November 12, 2024. (As Per BSE Announcement dated on 12.11.2024) | ||
| Board Meeting | 13 Aug 2024 | 5 Aug 2024 |
| Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve 1. To consider and approve Un-Audited Standalone and Consolidated Financial Results along with the Limited Review Report for the quarter ended June 30 2024; 2. Any other business with the permission of a Chairman. Outcome of the Meeting of Board of Directors held on Tuesday, August 13, 2024. (As Per BSE Announcement dated on 13.08.2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.